Passa al contenuto
Merck
Tutte le immagini(1)

Documenti

BP809

Cisplatin

British Pharmacopoeia (BP) Reference Standard

Sinonimo/i:

cis-Diammineplatinum(II) dichloride, cis-Dichlorodiammine platinum(II), cis-Platinum(II) diammine dichloride, Cisplatin

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula condensata:
Pt(NH3)2Cl2
Numero CAS:
15663-27-1
Peso molecolare:
300.05
Numero CE:
239-733-8
Numero MDL:
MFCD00011623
Codice UNSPSC:
41116107
NACRES:
NA.24

Grado

pharmaceutical primary standard

Famiglia di API

cisplatin

Forma fisica

solid

Durata

limited shelf life, expiry date on the label

Produttore/marchio commerciale

BP

Punto di fusione

270 °C (lit.)

applicazioni

pharmaceutical
pharmaceutical small molecule

Formato

neat

Temperatura di conservazione

2-8°C

Stringa SMILE

N.N.Cl[Pt]Cl

InChI

1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2
LXZZYRPGZAFOLE-UHFFFAOYSA-L

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Cisplatin BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Cisplatin Injection

    • Azioni biochim/fisiol

    Potent platinum-based antineoplastic agent. Forms cytotoxic adducts with the DNA dinucleotide d(pGpG), inducing intrastrand cross-links.

    Confezionamento

    Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

    Altre note

    Sales restrictions may apply.

    Prodotti correlati

    N° Catalogo
    Descrizione
    Determinazione del prezzo

    C2210000

    Cisplatin, European Pharmacopoeia (EP) Reference Standard

    Y0001019

    Cisplatin impurity B, European Pharmacopoeia (EP) Reference Standard

    Y0001018

    Cisplatin impurity A, European Pharmacopoeia (EP) Reference Standard

    1551300

    Potassium Trichloroammineplatinate, United States Pharmacopeia (USP) Reference Standard

    1672803

    Transplatin, United States Pharmacopeia (USP) Reference Standard

    1134357

    Cisplatin, United States Pharmacopeia (USP) Reference Standard

    PHR1624

    Cisplatin, Pharmaceutical Secondary Standard; Certified Reference Material

    BP510

    Potassium trichloroammineplatinate, British Pharmacopoeia (BP) Reference Standard

    BP544

    Transplatin, British Pharmacopoeia (BP) Reference Standard

    PHR3252

    Transplatin, pharmaceutical secondary standard, certified reference material

    Pittogrammi

    Skull and crossbonesHealth hazard
    GHS06,GHS08

    Avvertenze

    Danger

    Indicazioni di pericolo

    H300,H315,H317,H319,H334,H335,H350

    Classi di pericolo

    Acute Tox. 2 Oral - Carc. 1B - Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

    Organi bersaglio

    Respiratory system

    Codice della classe di stoccaggio

    6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

    Classe di pericolosità dell'acqua (WGK)

    WGK 3

    Punto d’infiammabilità (°F)

    Not applicable

    Punto d’infiammabilità (°C)

    Not applicable

    Choose from one of the most recent versions:

    Certificati d'analisi (COA)

    Lot/Batch Number

    Sorry, we don't have COAs for this product available online at this time.

    If you need assistance, please contact Servizio Clienti

    Possiedi già questo prodotto?

    I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

    Visita l’Archivio dei documenti

    I clienti hanno visto anche

    Slide 1 of 9

    1 of 9

    Doxorubicina 98.0-102.0% (HPLC)

    Sigma-Aldrich

    D1515

    Doxorubicina

    Oxaliplatin powder

    Sigma-Aldrich

    O9512

    Oxaliplatin

    Paclitaxel from Taxus brevifolia, ≥95% (HPLC), powder

    Sigma-Aldrich

    T7402

    Paclitaxel

    5-Fluorouracil ≥99% (HPLC), powder

    Sigma-Aldrich

    F6627

    5-Fluorouracil

    Potassium trichloroammineplatinate British Pharmacopoeia (BP) Reference Standard

    BP510

    Potassium trichloroammineplatinate

    Carboplatin An analog of Cisplatin with reduced nephrotoxicity. Displays potent antitumor activity.

    Millipore

    216100-M

    Carboplatin

    Doxorubicina British Pharmacopoeia (BP) Reference Standard

    BP990

    Doxorubicina

    vibrant-m

    Y0001019

    Cisplatin impurity B

    Oxaliplatin European Pharmacopoeia (EP) Reference Standard

    Y0000271

    Oxaliplatin

    Shihong Ma et al.
    Journal of cellular biochemistry, 121(5-6), 3256-3265 (2020-01-07)
    Aberrant activation of the Hedgehog (Hh)/Gli pathway contributes to the tumorigenesis of several human cancers, including ovarian cancers. We investigated the function of SMO on cell growth, drug resistance, and invasive ability in A2780/DDP cells. Moreover, we also tested the
    Ruiqian Li et al.
    International urology and nephrology, 52(1), 187-196 (2019-12-13)
    Cisplatin could result in a wide range of kidney injuries. During the pathogenetic process, the excessive generation of reactive oxygen species (ROS) induced by cisplatin has been regarded as the initial and critical role, by which DNA damage and cell
    Xiaochen Wang et al.
    Stem cells international, 2020, 8877577-8877577 (2020-09-05)
    Esophageal squamous cell carcinoma (ESCC) is a frequent malignant tumor with low 5-year overall survival. Targeting ESCC tumor-initiating cells (TICs) may provide a new research avenue to achieve better therapeutic effects of ESCC. However, the identity and characteristics of ESCC
    Teng Wang et al.
    Biochimica et biophysica acta. Molecular cell research, 1867(12), 118833-118833 (2020-08-30)
    Epithelial-mesenchymal transition (EMT) is considered as the key mechanism involved in cancer metastasis. Several studies showed that various cell membrane calcium channels play different roles in cancer metastasis. In the present study, the potential role of ATPase plasma membrane Ca2+
    Lan Wang et al.
    Marine drugs, 18(10) (2020-10-01)
    Ascomylactam A was reported for the first time as a new 13-membered-ring macrocyclic alkaloid in 2019 from the mangrove endophytic fungus Didymella sp. CYSK-4 from the South China Sea. The aim of our study was to delineate the effects of
    Visualizza tutti i documenti correlati

    Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

    Contatta l'Assistenza Tecnica.